Patent US4049496A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4049496A Expired / Lapsed US ⏱️ 0.0 years remaining

Rapid separation of plasma creatine kinase isoenzymes

Assignee: Individual
•
Filing: 1976-12-09
•
Granted: 1977-09-20
•
Expires: 1996-12-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An improved method for the rapid separation of the MM and MB creatine kinase isoenzymes is provided. The method involves the use of an ion exchange support material comprising porous glass beads having a stationary phase coupled to the surfaces thereof through an intermediate coupling agent. The intermediate coupling agent is preferably a silane coupling agent constituted by an organosilane with a silicon functional group capable of bonding to the surfaces of the glass beads and an organic functional group capable of bonding to the stationary phase. Less preferably, the coupling agent may be formed from a Grignard reagent of the formula RMgX where R is lower alkenyl and X is halogen. A blood plasma or serum sample and a buffer of low ionic strength are contacted with the ion exchange support, the resultant mixture is incubated to effect MB isoenzyme adsorption by the support, the supernatant liquid fraction containing the MM isoenzyme is separated from the support, the support is washed to effect a removal of residual of MM therefrom, a buffered solution of a strong electrolyte is added to the support to effect desorption of the MB isoenzyme therefrom and the supernatant liquid fraction containing the MB isoenzyme is separated from the support. The MM and MB activity in the respective liquid fractions thus obtained is then assayed to provide an index of myocardial damage.

Inventors

  • 👤 Philip D. Henry

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 14:46
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/43; A61K38/45; C; C12; C12Q; C12Q1/00; C12Q1/007; Y; Y10; Y10S; Y10S435/00; Y10S435/814; Y10S435/815

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 151 words
An in vitro method for effecting rapid separation of the MM and MB creatine kinase isoenzymes in blood plasma or serum and for determining the relative activities of the thus separated isoenzymes comprising the steps of contacting a blood plasma or serum sample and a buffer of low ionic strength with an ion exchange support comprising porous glass beads having a stationary phase coupled to the surfaces thereof through an intermediate coupling agent; incubating the resultant mixture to effect MB isoenzyme adsorption by said support; separating the supernatant liquid fraction containing the MM isoenzyme from said support; washing the support to effect removal of residual MM; adding a buffered solution of a strong electrolyte to said support to effect desorption of the MB isoenzyme therefrom; separating the supernatant liquid fraction containing the MB isoenzyme from said support; and assaying the MM and MB activity in the respective liquid fractions thus obtained.
Claim 2
Dependent Claim 151 words
An in vitro method for effecting rapid separation of the MM and MB creatine kinase isoenzymes in blood plasma or serum and for determining the relative activities of the thus separated isoenzymes comprising the steps of contacting a blood plasma or serum sample and a buffer of low ionic strength with an ion exchange support comprising porous glass beads having a stationary phase coupled to the surfaces thereof through an intermediate coupling agent; incubating the resultant mixture to effect MB isoenzyme adsorption by said support; separating the supernatant liquid fraction containing the MM isoenzyme from said support; washing the support to effect removal of residual MM; adding a buffered solution of a strong electrolyte to said support to effect desorption of the MB isoenzyme therefrom; separating the supernatant liquid fraction containing the MB isoenzyme from said support; and assaying the MM and MB activity in the respective liquid fractions thus obtained.
Claim 3
Dependent Claim 51 words
An in vitro method as set forth in claim 1 wherein said intermediate coupling agent is a silane coupling agent constituted by an organosilane with a silicon functional group capable of bonding to the surface of the glass beads and an organic functional group capable of bonding to the stationary phase.
Claim 4
Dependent Claim 22 words
An in vitro method as set forth in claim 2 wherein said organic functional group is a simple carbohydrate or carbohydrate derivative.
Claim 5
Dependent Claim 17 words
An in vtro method as set forth in claim 3 wherein said organic functional group is glycerol.
Claim 6
Dependent Claim 18 words
An in vitro method as set forth in claim 2 wherein said intermediate organosilane coupling agent is glycidoxypropyltrimethoxysilane.
Claim 7
Dependent Claim 20 words
An in vitro method as set forth in claim 2 wherein said stationary phase is derived from diethylamine or diethylaminoethanol.
Claim 8
Dependent Claim 34 words
An in vitro method as set forth in claim 1 wherein said intermediate coupling agent is formed from a Grignard reagent of the formula RMgX where R is lower alkenyl and X is halogen.
Claim 9
Dependent Claim 18 words
An in vitro method as set forth in claim 7 wherein said Grignard reagent is 1-butenyl magnesium bromide.
Claim 10
Dependent Claim 25 words
An in vitro method as set forth in claim 1 wherein the buffer of low ionic strength has a pH between approximately 7.1 and 9.0.
Claim 11
Dependent Claim 27 words
An in vitro method as set forth in claim 1 wherein the concentration of strong electrolyte in said buffered solution is between approximately 250 and 500 mmol/liter.
Claim 12
Dependent Claim 16 words
An in vitro method as set forth in claim 10 wherein the electrolyte is sodium chloride.
Claim 13
Dependent Claim 47 words
An in vitro method as set forth in claim 1 wherein the sample is blood plasma and the step of washing the support to effect removal of residual MM results in at least approximately a 1000 fold dilution of MM activity in the initial blood plasma sample.
Claim 14
Dependent Claim 24 words
An in vitro method as set forth in claim 1 wherein the resultant mixture from the first step is incubated for approximately three minutes.
Claim 15
Dependent Claim 25 words
An in vitro method as set forth in claim 1 wherein said incubating and separating steps are carried out by means of a filter sampler.

References Cited (Backward Citations)

US3994783A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-09-19 1981-03-21 1981-09-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-09-19 1985-03-21 1985-09-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-09-19 1989-03-21 1989-09-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag